Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,524,759
+$365,333 QoQ
Shares Held
16,110
+14.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#387
of 1,603 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Csenge Advisory Group holds $34,699,600 across 10 Drug Manufacturers - General names. NVS ranks #7 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,327 | $6,389,364 | |
| 2 | ABBV |
AbbVie Inc.
|
25,158 | $6,330,759 | |
| 3 | JNJ |
Johnson & Johnson
|
18,196 | $4,621,238 | |
| 4 | AMGN |
Amgen Inc
|
10,362 | $3,752,287 | |
| 5 | PFE |
Pfizer Inc
|
154,984 | $3,732,014 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
22,416 | $2,832,037 | |
| 7 | NVS |
Novartis AG
This page
|
16,110 | $2,524,759 | |
| 8 | GSK |
GSK plc
|
41,506 | $2,175,744 |
All Filings in NVS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,524,759 | 16,110 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,159,426 | 14,137 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $4,172,497 | 30,264 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,750,507 | 29,246 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $2,227,552 | 18,408 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $2,003,964 | 17,976 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,595,397 | 16,395 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,153,190 | 10,026 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $995,188 | 9,348 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $634,161 | 6,556 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $799,783 | 7,921 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $724,733 | 7,115 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $343,699 | 3,406 | Shares | Sole | 2023-07-20 | |
| 2021-03-31 | $197,629 | 2,312 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $232,581 | 2,463 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $253,227 | 2,912 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $250,229 | 2,865 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $281,731 | 3,417 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||